SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hindustan Bio Sciences informs about newspaper publication

02 Jun 2026 Evaluate
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Hindustan Bio Sciences has informed that the Audited financial results of the Company for the quarter and year ended March 31, 2026 were published by the company on 02-06-2026 in Hitech Edition (in English language) and 01-06-2026 in The Praja Palana (in Telugu language) newspapers. A copy of same is enclosed. This intimation shall also be available on the Company’s website at www.hindustanbiosciences.in.

The above information is a part of company’s filings submitted to BSE. 

Hind Bio Science Share Price

7.99 0.29 (3.77%)
12-Jun-2026 10:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.45
Dr. Reddys Lab 1268.35
Cipla 1385.40
Zydus Lifesciences 1114.20
Lupin 2273.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: